Evaluation of CD56 and CD117 Double-Positivity as a Predictor of Poor Prognosis in Multiple Myeloma Patients: A Retrospective Analysis
Objective: Despite advancements in treatment, multiple myeloma (MM) remains a challenging hematologic malignancy. It is crucial to stratify risk and perform prognostic assessment with various markers, including the expression of cluster of differentiation 56 (CD56) and cluster of differentiation 117...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Turkish Society of Hematology
2024-12-01
|
| Col·lecció: | Turkish Journal of Hematology |
| Matèries: | |
| Accés en línia: | https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-14306 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|